Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

AC Immune (ACIU) FCF Margin (2016 - 2025)

AC Immune has reported FCF Margin over the past 8 years, most recently at 4918.05% for Q4 2025.

  • Quarterly FCF Margin fell 544786.0% to 4918.05% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 1372.9% through Mar 2026, down 152777.0% year-over-year, with the annual reading at 1961.1% for FY2025, 220431.0% down from the prior year.
  • FCF Margin was 4918.05% for Q4 2025 at AC Immune, down from 1983.17% in the prior quarter.
  • Over five years, FCF Margin peaked at 10639.74% in Q2 2024 and troughed at 4918.05% in Q4 2025.
  • The 3-year median for FCF Margin is 778.01% (2025), against an average of 92.34%.
  • The largest YoY upside for FCF Margin was -192834bps in 2025 against a maximum downside of -1185176bps in 2025.
  • A 3-year view of FCF Margin shows it stood at 344.0% in 2022, then skyrocketed by 254bps to 529.82% in 2024, then plummeted by -1028bps to 4918.05% in 2025.
  • Per Business Quant, the three most recent readings for ACIU's FCF Margin are 4918.05% (Q4 2025), 1983.17% (Q3 2025), and 1212.02% (Q2 2025).